Our new San Diego location is currently under development, and will include more than 63,000 square feet of mixed-use space optimized for both laboratory operations and research and development. The office will consolidate the company’s two San Diego locations under one roof in Torrey Pines, the center of the city’s life science cluster.
|Sr Project Manager||ctDNA-Research and Early Development||102355||San Diego. Cambridge||California. Massachusetts||United States||Torreyana Road, San Diego, California, United States. Cambridge, Massachusetts, United States||R&D||About the Job The Senior Project Manager, Early Detection is responsible for the planning and execution of new biopharma clinical product development projects and/or lab expansion projects, as well as other business critical initiatives. The rol...|
|Scientist II, Computational Biology||Computational Biology||102353||San Diego||California||United States||Torreyana Road, San Diego, California, United States||R&D||About the Job The Scientist II, Computational Biology on the Computational Biology team collaborates with a multidisciplinary team of scientists by developing the computational analytics components of future products and enriching the analytical...|
|Intern, Process Excellence MBA (SAN)||Strategic Initiatives and Process Excellence||102319||San Diego||California||United States||Torreyana Road, San Diego, California, United States||Operations||About the Job The Intern, Process Excellence is responsible for assisting in driving successful implementation of improvement projects across the enterprise, enabling FMI to continue rapid growth and the drive towards profitability. The position...|
|Senior Scientist, Early Research & Development||ctDNA-Research and Early Development||100911||San Diego||California||United States||Torreyana Road, San Diego, California, United States||R&D||About the Job The Senior Scientist is part of the Research and Early Development group within FMI’s R&D function. This position explores new technologies and biomarker modalities to address unmet needs in the oncology field using liquid biopsy. ...|
The new laboratory space will help to expand testing capacity of the company’s recently FDA-approved FoundationOne Liquid CDx liquid biopsy test. Additionally, with Foundation Medicine’s acquisition of Lexent Bio* in June, the new space will allow for increased research and development of low-pass whole genome sequencing and DNA methylation analysis. The site hosts the following teams - Laboratory Operations, Facilities, Technology, TOCR, Research and Development (Early Research and Assay Development), Medical, and Legal teams. Client Services and other teams will be there as well soon.
“This state-of-the-art facility provides the opportunity to further expand our R&D and laboratory operations and supports our focus on advancing personalized medicine for patients,” said Foundation Medicine’s Chief Scientific Officer Priti Hegde, Ph.D. “The San Diego region is home to more than 1,200 life sciences companies—we’re excited to embed ourselves in this burgeoning community, deepen our local partnerships and add this high-quality lab space to expand into new projects.”
Foundation Medicine’s labs in Cambridge; Research Triangle Park, North Carolina; and Penzberg, Germany will continue to analyze individual patients’ genomic profiles, using the company’s portfolio of genomic tests, to identify the molecular alterations in a patient's cancer and help physicians match them with relevant personalized treatment approaches, including targeted therapies, immunotherapies and clinical trial options.
Molecular Technologist: from Cambridge to San Diego
"What kept me coming back for three internships and eventually a full-time position was the leadership I found here. The high level of genuine support was something I hadn’t felt before. The way everyone approaches problem-solving and encourages out-of-the-box ideas is spectacular. Something about me that hasn’t changed since the first day I started at Foundation Medicine is the constant urge to challenge myself. Therefore, I’m extremely excited for my move to the new San Diego lab, as well as my new position as Molecular Technologist II"
Read more about Sabrina's career growth and relocation to the West Coast here.
Location Spotlight: San Diego
Foundation Medicine’s new facility in Torrey Pines, which became occupied in Fall 2021, consolidates the company’s two previous California locations under one roof and includes more than 80,000 square feet of mixed-use space optimized for both Laboratory Operations and Research and Development. They look forward to leveraging this new state-of-the-art facility to accelerate Research and Development and expand Foundation Medicine’s existing liquid biopsy platforms to continue to transform cancer care for patients.
Read more about our San Diego site here.
In June of 2020, we completed the acquisition of Lexent Bio, Inc., a precision oncology company located in California, developing novel multiomics liquid biopsy platforms to advance cancer care. This acquisition will accelerate our research and development strategy and expand its existing liquid biopsy platforms to advance cancer care for patients. The technology developed by Lexent Bio complements our existing efforts and partnerships aimed at developing advanced diagnostics for physicians, as well as genomically evaluating disease progression and informing treatment decisions at earlier stages of disease. Read more here.
Automation Engineer: from Cambridge to San Diego
"The path that brought me to Foundation Medicine, and then to our new San Diego location is what I would describe as a perfect opportunity. It wasn’t a hard decision to move from the east coast to the west coast. My family is located around the San Diego area, and I’m so excited about the future of our San Diego location."
- Jun, Senior Automation Engineer
Read more about Jun's relocation to the West Coast here.
Enter your details and we will notify you when new roles that might be a fit are posted!